Skip to content
The Nexus
DossierENTITY

advanced lung cancer

Coverage of advanced lung cancer in the Nexus archive.

Earliest in view: Jun 10 · 08:03 UTCMost recent: Jun 10 · 08:03 UTC
Co-mentioned in this coverage
Chinese University of Hong Kongorganization1Hong Kongplace1lorlatinibtopic1targeted therapytopic1
Recent coverage
  • HEALTHJun 10 · 08:03 UTCSCMP CHINA
    Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study

    A Hong Kong co-led global study found that the third-generation targeted therapy lorlatinib kept over half of advanced lung cancer patients alive without disease progression for at least seven years, potentially transforming the disease into a chronic condition. The research was conducted by the Chinese University of Hong Kong.